Cover Image

Docosahexaenoic Acid Inhibits Cell Proliferation through a Suppression of c-Myc Protein in Pancreatic Ductal Adenocarcinoma Cells

Treatment of pancreatic cancer by inhibiting the aberrant activation of the survival signaling pathways has received considerable attention. We investigated the probable action of DHA on the suppression of cell proliferation in human pancreatic ductal adenocarcinoma (PDAC) cells. Our results demonst...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jia-Ning Syu (Author), Der-Yen Lee (Author), Hung-Chang Hung (Author), Chia-Ying Li (Author), Hung-Yu Lin (Author), En-Pei Isabel Chiang (Author), Yi-Heng Chen (Author), Shu-Ming Huang (Author), Feng-Yao Tang (Author)
Format:	Book
Published:	MDPI AG, 2021-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

1,2,3,4,6-Penta-O-Galloyl-Beta-D-Glucopyranoside Inhibits Proliferation of Multiple Myeloma Cells Accompanied with Suppression of MYC Expression
by: Duurenjargal Tseeleesuren, et al.
Published: (2018)

Cancer stem cells and mesenchymal stem cells in pancreatic ductal adenocarcinoma
by: V. O. Tumanskyi, et al.
Published: (2019)

Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinoma Cells
by: Changpeng Cui, et al.
Published: (2023)

Pathomorphological description of proliferation and apoptosis processes in pancreatic intraepithelial neoplasia in the pancreatic ductal adenocarcinoma and chronic pancreatitis
by: V. A. Tumanskiy, et al.
Published: (2014)

Surgical Treatment of Pancreatic Ductal Adenocarcinoma
Published: (2021)

Changes in the transcriptional activity of cell cycle regulator CDK1 and cell proliferation ki67 genes in invasive and non-invasive pancreatic ductal adenocarcinoma
by: A. V. Evseyev, et al.
Published: (2016)

Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma
by: Norihiro Sato, et al.
Published: (2016)

Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
by: Alexander G. Raufi, et al.
Published: (2021)

Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
by: Rita Rebelo, et al.
Published: (2021)

Brusatol increases chemotherapeutic drug efficacy in pancreatic ductal adenocarcinoma by suppressing Nrf2 signaling
by: Juan Zhang, et al.
Published: (2024)

Docosahexaenoic acid (DHA) effects on proliferation and steroidogenesis of bovine granulosa cells
by: Virginie Maillard, et al.
Published: (2018)

Biliary Tract Microbiota Similarities in Pancreatic Ductal Adenocarcinoma
by: Ariel A. Arteta
Published: (2021)

Hydrogel-Based Therapeutics for Pancreatic Ductal Adenocarcinoma Treatment
by: Jinlu Liu, et al.
Published: (2023)

Retraction: High expression of long noncoding RNA HOTAIRM1 is associated with the proliferation and migration in pancreatic ductal adenocarcinoma
by: Pathology & Oncology Research Editorial Office
Published: (2024)

Analysis of a novel immune checkpoint, Siglec‐15, in pancreatic ductal adenocarcinoma
by: Xianlong Chen, et al.
Published: (2022)

Cordycepin inhibits colon cancer proliferation by suppressing MYC expression
by: Zhe Zhang, et al.
Published: (2022)

Cell block created from pancreatic duct lavage is another jigsaw puzzle to diagnose early pancreatic ductal adenocarcinoma
by: Rungsun Rerknimitr
Published: (2023)

Pancreatic duct lavage cytology combined with a cell-block method for patients with possible pancreatic ductal adenocarcinomas, including pancreatic carcinoma
by: Hiroaki Kusunose, et al.
Published: (2023)

Quantitative indexes of stromal markers expression in the pancreatic ductal adenocarcinoma and chronic pancreatitis
by: V. A. Tumanskiy, et al.
Published: (2015)

Immune cell infiltrates as prognostic biomarkers in pancreatic ductal adenocarcinoma: a systematic review and meta‐analysis
by: Andrew J McGuigan, et al.
Published: (2021)

Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy
by: Verena Hofschröer, et al.
Published: (2021)

Ion Channel Signature in Healthy Pancreas and Pancreatic Ductal Adenocarcinoma
by: Julie Schnipper, et al.
Published: (2020)

Heterogeneity of weight loss and transcriptomic signatures in pancreatic ductal adenocarcinoma
by: Andrea N. Riner, et al.
Published: (2024)

A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics
by: Ozhan Ocal, et al.
Published: (2015)

The Importance of Stroma and Stromal SMA Expression in Pancreatic Ductal Adenocarcinoma
by: Gamze AKBAS, et al.
Published: (2024)

RETRACTED: Knockdown EIF3C Suppresses Cell Proliferation and Increases Apoptosis in Pancreatic Cancer Cell
by: Heng Jiao, et al.
Published: (2020)

A Bitter Taste Receptor as a Novel Molecular Target on Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma
by: Jessica Hung, et al.
Published: (2023)

Clinical application of pancreatic juice‐derived small extracellular vesicles of pancreatic ductal adenocarcinoma
by: Koichiro Tsutsumi, et al.
Published: (2023)

The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma
by: Ren L, et al.
Published: (2018)

Circular RNA Signature Predicts Gemcitabine Resistance of Pancreatic Ductal Adenocarcinoma
by: Feng Shao, et al.
Published: (2018)

Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy
by: Wanting Hou, et al.
Published: (2022)

HOXA9 and CD163 potentiate pancreatic ductal adenocarcinoma progression
by: Aiat Shaban Hemida, et al.
Published: (2024)

Evening Primrose Oil Improves Chemotherapeutic Effects in Human Pancreatic Ductal Adenocarcinoma Cell Lines-A Preclinical Study
by: Laura Zeppa, et al.
Published: (2022)

Repurposing econazole as a pharmacological autophagy inhibitor to treat pancreatic ductal adenocarcinoma
by: Ningna Weng, et al.
Published: (2022)

Nimbolide Inhibits SOD2 to Control Pancreatic Ductal Adenocarcinoma Growth and Metastasis
by: Tugba Mehmetoglu-Gurbuz, et al.
Published: (2023)

Investigation of HNF-1B as a diagnostic biomarker for pancreatic ductal adenocarcinoma
by: Michelle X. Yang, et al.
Published: (2018)

Metastatic pancreatic ductal adenocarcinoma in a teenage girl: A rare disease
by: Sutaryo Sutaryo, et al.
Published: (2020)

An indolent pancreatic ductal adenocarcinoma with psammoma bodies and a coincidental neuroendocrine tumor
by: Hongxing Gui, et al.
Published: (2019)

Validation of a targeted next-generation sequencing panel for pancreatic ductal adenocarcinomas
by: Marie-Lucie Racu, et al.
Published: (2024)

Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma
by: Lili Wang, et al.
Published: (2017)